About
PanTera is a joint venture between IBA and SCK CEN that develops and scales production of the radioisotope actinium-225 (Ac-225) to supply radiopharmaceutical manufacturers for targeted alpha therapy and theranostic cancer treatments. The company focuses on securing large-scale commercial supply chains for Ac-225 to improve access to Ac-225-based therapies.
Explore Pantera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.